Evidence map›Paper›PMID 31775483›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2019

[Gene mutation spectrum and clinical characteristics analysis of 178 patients with essential thrombocytosis].

H Dong, R F Fu, M K Ju, T Sun, X F Liu, F Xue, Y Chi, R C Yang, L Zhang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

H DongThe State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College.Tianjin Key Laboratory of Gene Therapy for Blood diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin 300020, China.
R F Fu
M K Ju
T Sun
X F Liu
F Xue
Y Chi
R C Yang
L Zhang
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

CAMS Initiative for Innovative Medicine 2016-I2M-1-018, 2017-I2M-1-015CAMS Key Laboratory of Gene Therapy for Blood Diseases 2017PT31047, 2018PT31038National Natural Science Foundation of China 81470302, 81600099, 81500084The Beijing-Tianjin-Hebei Basic Research Project 18JCZDJC44600, H2018206423Tianjin Research Program of Application Foundation and Advanced Technology 18JCQNJC11900
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAged, 80 and overCalreticulinChildChild, PreschoolFemaleHumansJanus Kinase 2MaleMiddle AgedMutationReceptors, ThrombopoietinRetrospective StudiesThrombocythemia, EssentialCalreticulinJanus Kinase 2Receptors, ThrombopoietinClinical StudyEssential thrombocytosisGene mutation

Identifiers

PMID31775483
PMCPMC7364978
OpenAlexW2991175486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.